Nav: Home

In effort to treat rare blinding disease, researchers turn stem cells into blood vessels

February 13, 2018

People who inherit a mutated version of the ATF6 gene are born with a malformed or missing fovea, the eye region responsible for sharp, detailed vision. From birth, their vision is severely limited, and there is no cure. Jonathan Lin, MD, PhD, associate professor of pathology at University of California San Diego School of Medicine and Shiley Eye Institute, and team were the first to link ATF6 to this type of inherited vision impairment.

Now, in a study published February 13 in Science Signaling, Lin's team discovered that a chemical compound that activates ATF6 also converts patient-derived stem cells into blood vessels.

"We wanted to see if there was a way to correct this gene defect to restore function and help these patients with vision difficulties and blindness," Lin said. "But it turns out our findings could also help advance the development of new treatments for other diseases caused by lack of blood supply to an organ, such as occurs in stroke and heart attack."

The ATF6 protein is a transcription factor, meaning it helps turn other genes "off" or "on," depending on what's needed by the cell. ATF6 is normally activated when the cell is under stress due to the accumulation of unfolded or misfolded proteins. Lin's team previously found that ATF6 is naturally "on" during stem cell development.

After Lin's team first published the link between the ATF6 gene and this type of inherited vision loss, known as achromatopsia or cone-rod dystrophy, a few years ago, people with these conditions began contacting them from around the world. Many had never known the cause of their vision problems and they were eager to see if they had a mutated copy of the ATF6 gene. They were also eager to contribute to research that would further the understanding of the disease and efforts to find a treatment.

For this latest study, Lin's team collected donated skin samples from a family living in New York. Three children in this family were born without fully functioning ATF6 genes. The researchers dialed the skin cells back, developmentally speaking, to produce induced pluripotent stem cells (iPSCs) -- a special type of cell that can both self-renew, making more iPSCs, and differentiate, specializing into almost any other cell type.

Meanwhile, collaborators at The Scripps Research Institute screened millions of chemical compounds, using robotic technology to test each for their abilities to activate ATF6. They found 10 compounds that looked promising and gave them to Lin's team for testing on the stem cells.

"We weren't sure what to expect," Lin said. "We just hoped one of these compounds would have some kind of positive effect."

That's why the team was particularly surprised, Lin said, when they saw the effects of one of these compounds, known as AA147. Not only did treatment with the AA147 compound activate ATF6 in stem cells, it altered the cells' differentiation path. AA147 directed the stem cells to develop primarily into endothelial cells, which are essential for blood vessel formation.

"Normally, stem cells differentiate into many different cell types and it's difficult to get them to produce a good amount of any one specific cell type," Lin said. "Yet after AA147 treatment, around 70 percent of the culture turned into endothelial cells that were able to form blood vessels. That's the most efficient way to experimentally produce blood vessels that I know of."

Lin cautioned that AA147 is not yet a "bona fide drug" for many reasons. First, the effects they saw have so far only been replicated in cells growing in a laboratory dish, using high concentrations of AA147. They are now developing newer generations of the compound that are more potent at lower doses. Ultimately, AA147 -- or some version of it -- would need to undergo clinical trials for safety and efficacy before it could potentially be used to treat patients.

In the meantime, Lin said, the study provides valuable new information on ATF6's role in human development and how its malfunctioning can lead to blindness.
-end-
Study co-authors also include Heike Kroeger, Neil Grimsey, Wei-Chieh Chiang, Ying Jones, Peter X. Shaw, JoAnn Trejo, UC San Diego; Ryan Paxman, Lars Plate, Evan Powers, Jeffery W. Kelly, R. Luke Wiseman, The Scripps Research Institute; and Stephen H. Tsang, New York Presbyterian Hospital, Columbia University.

This research was funded, in part, by the National Institutes of Health (grants EY027335, NS088485, EY018213, EY024698, EY026682, AG050437, EY019007, CA013696, EY022589, UL1TR001114, AG046495), U.S. Department of Veterans Affairs (merit awards I01BX002284, I01RX002340) and New York State (grants N09G-302, N13G-275).

University of California - San Diego

Related Stem Cells Articles:

A protein that stem cells require could be a target in killing breast cancer cells
Researchers have identified a protein that must be present in order for mammary stem cells to perform their normal functions.
Approaching a decades-old goal: Making blood stem cells from patients' own cells
Researchers at Boston Children's Hospital have, for the first time, generated blood-forming stem cells in the lab using pluripotent stem cells, which can make virtually every cell type in the body.
New research finds novel method for generating airway cells from stem cells
Researchers have developed a new approach for growing and studying cells they hope one day will lead to curing lung diseases such as cystic fibrosis through 'personalized medicine.'
Mature heart muscle cells created in the laboratory from stem cells
Generating mature and viable heart muscle cells from human or other animal stem cells has proven difficult for biologists.
Mutations in bone cells can drive leukemia in neighboring stem cells
DNA mutations in bone cells that support blood development can drive leukemia formation in nearby blood stem cells.
Scientists take aging cardiac stem cells out of semiretirement to improve stem cell therapy
With age, the chromosomes of our cardiac stem cells compress as they move into a state of safe, semiretirement.
Purest yet liver-like cells generated from induced pluripotent stem cells
A team of researchers from the Medical University of South Carolina and elsewhere has found a better way to purify liver cells made from induced pluripotent stem cells.
Stem cell scientists discover genetic switch to increase supply of stem cells from cord blood
International stem cell scientists, co-led in Canada by Dr. John Dick and in the Netherlands by Dr.
Stem cells from diabetic patients coaxed to become insulin-secreting cells
Signaling a potential new approach to treating diabetes, researchers at Washington University School of Medicine in St.

Related Stem Cells Reading:

Stem Cell Therapy: A Rising Tide: How Stem Cells Are Disrupting Medicine and Transforming Lives
by Neil H Riordan (Author)

Stem Cells: A Short Course
by Rob Burgess (Author)

The Stem Cell Revolution
by Mark Berman MD (Author), Elliot Lander MD (Contributor)

Essentials of Stem Cell Biology
by Robert Lanza (Editor), Anthony Atala (Editor)

Stem Cells: An Insider's Guide
by Paul Knoepfler (Author)

Engineering Stem Cells for Tissue Regeneration
by Ngan F Huang (Author), Ngan F Huang (Editor), Nicolas L'Heureux (Editor), Song L (Editor)

Stem Cells For Dummies
by Lawrence S.B. Goldstein (Author), Meg Schneider (Author)

Stem Cell Revolution: Discover 26 Disruptive Technological Advances to Stem Cell Activation
by Joseph Christiano (Author)

Stem Cells: Promise And Reality
by Lygia V Pereira (Author)

The Science of Stem Cells
by Jonathan M. W. Slack (Author)

Best Science Podcasts 2018

We have hand picked the best science podcasts for 2018. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Circular
We're told if the economy is growing, and if we keep producing, that's a good thing. But at what cost? This hour, TED speakers explore circular systems that regenerate and re-use what we already have. Guests include economist Kate Raworth, environmental activist Tristram Stuart, landscape architect Kate Orff, entrepreneur David Katz, and graphic designer Jessi Arrington.
Now Playing: Science for the People

#504 The Art of Logic
How can mathematics help us have better arguments? This week we spend the hour with "The Art of Logic in an Illogical World" author, mathematician Eugenia Cheng, as she makes her case that the logic of mathematics can combine with emotional resonance to allow us to have better debates and arguments. Along the way we learn a lot about rigorous logic using arguments you're probably having every day, while also learning a lot about our own underlying beliefs and assumptions.